50 research outputs found

    Absence of Nodal signaling promotes precocious neural differentiation in the mouse embryo

    Get PDF
    AbstractAfter implantation, mouse embryos deficient for the activity of the transforming growth factor-ÎČ member Nodal fail to form both the mesoderm and the definitive endoderm. They also fail to specify the anterior visceral endoderm, a specialized signaling center which has been shown to be required for the establishment of anterior identity in the epiblast. Our study reveals that Nodal−/− epiblast cells nevertheless express prematurely and ectopically molecular markers specific of anterior fate. Our analysis shows that neural specification occurs and regional identities characteristic of the forebrain are established precociously in the Nodal−/− mutant with a sequential progression equivalent to that of wild-type embryo. When explanted and cultured in vitro, Nodal−/− epiblast cells readily differentiate into neurons. Genes normally transcribed in organizer-derived tissues, such as Gsc and Foxa2, are also expressed in Nodal−/− epiblast. The analysis of Nodal−/−;Gsc−/− compound mutant embryos shows that Gsc activity plays no critical role in the acquisition of forebrain characters by Nodal-deficient cells. This study suggests that the initial steps of neural specification and forebrain development may take place well before gastrulation in the mouse and highlights a possible role for Nodal, at pregastrula stages, in the inhibition of anterior and neural fate determination

    Regionalization of the mouse visceral endoderm as the blastocyst transforms into the egg cylinder.

    Get PDF
    BACKGROUND: Reciprocal interactions between two extra-embryonic tissues, the extra-embryonic ectoderm and the visceral endoderm, and the pluripotent epiblast, are required for the establishment of anterior-posterior polarity in the mouse. After implantation, two visceral endoderm cell types can be distinguished, in the embryonic and extra-embryonic regions of the egg cylinder. In the embryonic region, the specification of the anterior visceral endoderm (AVE) is central to the process of anterior-posterior patterning. Despite recent advances in our understanding of the molecular interactions underlying the differentiation of the visceral endoderm, little is known about how cells colonise the three regions of the tissue. RESULTS: As a first step, we performed morphological observations to understand how the extra-embryonic region of the egg cylinder forms from the blastocyst. Our analysis suggests a new model for the formation of this region involving cell rearrangements such as folding of the extra-embryonic ectoderm at the early egg cylinder stage. To trace visceral endoderm cells, we microinjected mRNAs encoding fluorescent proteins into single surface cells of the inner cell mass of the blastocyst and analysed the distribution of labelled cells at E5.0, E5.5 and E6.5. We found that at E5.0 the embryonic and extra-embryonic regions of the visceral endoderm do not correspond to distinct cellular compartments. Clusters of labelled cells may span the junction between the two regions even after the appearance of histological and molecular differences at E5.5. We show that in the embryonic region cell dispersion increases after the migration of the AVE. At this time, visceral endoderm cell clusters tend to become oriented parallel to the junction between the embryonic and extra-embryonic regions. Finally we investigated the origin of the AVE and demonstrated that this anterior signalling centre arises from more than a single precursor between E3.5 and E5.5. CONCLUSION: We propose a new model for the formation of the extra-embryonic region of the egg cylinder involving a folding of the extra-embryonic ectoderm. Our analyses of the pattern of labelled visceral endoderm cells indicate that distinct cell behaviour in the embryonic and extra-embryonic regions is most apparent upon AVE migration. We also demonstrate the polyclonal origin of the AVE. Taken together, these studies lead to further insights into the formation of the extra-embryonic tissues as they first develop after implantation.RIGHTS : This article is licensed under the BioMed Central licence at http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'. In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are

    Investigation of photocurrents resulting from a living unicellular algae suspension with quinones over time

    Get PDF
    International audiencePlants, algae, and some bacteria convert solar energy into chemical energy by using photosynthesis. In light of the current energy environment, many research strategies try to benefit from photosynthesis in order to generate usable photobioelectricity. Among all the strategies developed for transferring electrons from the photosynthetic chain to an outer collecting electrode, we recently implemented a method on a preparative scale (high surface electrode) based on a Chlamydomonas reinhardtii green algae suspension in the presence of exogenous quinones as redox mediators. While giving rise to an interesting performance (10-60 mA cm À2) in the course of one hour, this device appears to cause a slow decrease of the recorded photocurrent. In this paper, we wish to analyze and understand this gradual fall in performance in order to limit this issue in future applications. We thus first show that this kind of degradation could be related to over-irradiation conditions or side-effects of quinones depending on experimental conditions. We therefore built an empirical model involving a kinetic quenching induced by incubation with quinones, which is globally consistent with the experimental data provided by fluorescence measurements achieved after dark incubation of algae in the presence of quinones

    miRNA in embryonic development: the taming of Nodal signaling.

    Get PDF
    International audienceThe TGF-beta family member Nodal is one of the most potent molecules known to an embryo. Studies on Nodal regulation thus far have focused on its transcription, maturation, and interaction with antagonists. Two recent studies on the role of microRNAs (miRNAs) in Nodal signaling now reveal that something important was missing from the picture

    Faut-il faire Ă©voluer la prise en charge de l'infection par helicobacter pylori?

    No full text
    L'infection Ă  Helicobacter pylori (Hp) est associĂ©e Ă  de nombreuses maladies gastro-duodĂ©nales : dyspepsie, maladie ulcĂ©reuse gastro-duodĂ©nale liĂ©e ou non Ă  la prise d'aspirine ou d'anti-inflammatoires, reflux gastro-oesophagien, lymphome du MALT et cancer gastrique. Selon la confĂ©rence de consensus de 1999 la recherche d'Hp et son traitement sont recommandĂ©s uniquement chez les patients ayant des lĂ©sions ulcĂ©rĂ©es et/ou un lymphome gastrique du MALT, pour qui la prise en charge recommandĂ©e est toujours d'actualitĂ©. Selon certaines Ă©tudes le bĂ©nĂ©fice de l'Ă©radication d'Hp est faible dans la dyspepsie et non justifiĂ© dans le reflux gastro-oesophagien oĂč l'infection par Hp pourrait avoir un rĂŽle protecteur. D'autres Ă©tudes suggĂšrent l'intĂ©rĂȘt de l'Ă©radication prĂ©ventive avant la prise d'anti-inflammatoires ou par aspirine Ă  faible dose. Les progrĂšs les plus importants rĂ©alisĂ©s ces derniĂšres annĂ©es concernent Hp et le cancer gastrique en faveur d'une Ă©radication de la bactĂ©rie chez les parents du premier degrĂ© des sujets ayant un cancer gastrique. En conclusion, il n'apparaĂźt pas justifiĂ© pour le moment de modifier les recommandations de la confĂ©rence de consensus de 1999, mais il semble opportun de modifier la prise en charge au cas par cas.CHATENAY M.-PARIS 11-BU Pharma. (920192101) / SudocSudocFranceF

    Etude fonctionnelle d'un élément auto-régulateur du gÚne Nodal au cours du développement précoce de la souris

    No full text
    Le travail dĂ©crit dans ce manuscrit est une Ă©tude du fonctionnement de la voie de signalisation du facteur de type TGF-beta Nodal pendant l embryogenĂšse prĂ©coce de la souris. Ce travail est centrĂ© sur l analyse de l activitĂ© de l ASE, une sĂ©quence rĂ©gulatrice du gĂšne Nodal. Cette sĂ©quence est une cible de la voie de signalisation Smad2,3, qui transduit le signal Nodal, et permet donc au gĂšne Nodal d amplifier sa propre expression. Des lignĂ©es transgĂ©niques oĂč l expression de protĂ©ines fluorescentes est placĂ©e sous le contrĂŽle de l ASE avaient Ă©tĂ© gĂ©nĂ©rĂ©es au laboratoire. La caractĂ©risation de ces lignĂ©es et leur comparaison avec d autres lignĂ©es transgĂ©niques a permis de les valider en tant que lignĂ©es rapportrices de l activitĂ© de =l Ă©lĂ©ment rĂ©gulateur ASE. Une lignĂ©e ASE-YFP a Ă©tĂ© retenue pour la suite de l Ă©tude. L analyse du profil d expression du transgĂšne a rĂ©vĂ©lĂ© qu il est actif dĂšs les stades prĂ©-implantatoires. Ceci a suggĂ©rĂ© implication de l ASE dans l initiation de l expression de Nodal. Entre E3,5 et E4,5, nous avons observĂ© que l expansion de l activitĂ© du transgĂšne passe par des pĂ©riodes alternĂ©es de relative stabilitĂ© et d accroissement rapide. Deux courtes pĂ©riodes de propagation rapide de l activitĂ© de l ASE semblent correspondre Ă  la diffĂ©renciation de l endoderme primitif et Ă  l implantation, deux Ă©vĂ©nements majeurs du dĂ©veloppement embryonnaire Ă  ces stades. L observation que le transgĂšne ASE-YFP Ă  E3,5 est exprimĂ© façon poivre et sel dans les cellules de l ICM a soulevĂ© une interrogation quand aux destins relatifs des deux populations de cellules ainsi identifiĂ©es au sein de ce tissu pluripotent. Des Ă©tudes de co-marquage ont permis de montrer que l activitĂ© du transgĂšne ASE-YFP marque indiffĂ©remment aussi bien des prĂ©curseurs de l Ă©piblaste, qui expriment le facteur de pluripotence Nanog, que des prĂ©curseurs de l endoderme primitif, qui expriment Gata4. Cependant, les co-marquages rĂ©alisĂ©s aprĂšs la formation de l endoderme primitif indiquent qu au sein de l Ă©piblaste l expansion du nombre de cellules exprimant le transgĂšne ASE-YFP est concomitante d une diminution du nombre de cellules exprimant Nanog. De façon intĂ©ressante, le pool des cellules co-exprimant Nanog et le transgĂšne ASE-YFP dĂ©croĂźt plus lentement que la population des cellules exprimant Nanog seul. Ceci apporte un Ă©clairage nouveau aux donnĂ©es impliquant la signalisation Nodal dans le maintien de la pluripotence, et suggĂšre que l activitĂ© de la voie de signalisation de Nodal et le facteur Nanog, pourraient ĂȘtre liĂ©s via l ASE au sein d une mĂȘme boucle de rĂ©gulation.Enfin, la rĂ©gulation de l ASE aux stades prĂ© et pĂ©ri-implantatoires a Ă©tĂ© Ă©tudiĂ©e par une approche combinant gĂ©nĂ©tique et inhibition pharmacologique. L utilisation d un inhibiteur spĂ©cifique des rĂ©cepteurs ALK4, 5, 7 qui normalement participent Ă  l activation de Smad2,3, a permis de dĂ©montrer que l activation du transgĂšne est bien dĂ©pendante de cette voie de signalisation Ă  ces stades. Cependant, le maintien de l activitĂ© du transgĂšne ASE-YFP en contexte mutant pour Nodal indique qu un autre ligand que Nodal contribue alors Ă  l activitĂ© de la voie. De mĂȘme, le maintien de l activitĂ© du transgĂšne en contexte mutant pour Foxh1, l effecteur classique de Smad2,3 dans l Ă©piblaste, confirme que d autres acteurs que ceux dĂ©jĂ  identifiĂ©s sont impliquĂ©s dans l activitĂ© de la voie Smad2,3 Ă  ces stades. Il est Ă  noter que l extinction du transgĂšne par l inhibiteur pharmacologique ne s accompagne pour les embryons traitĂ©s d aucun effet visible sur leur croissance ou leur physiologie. L ensemble de ces travaux prĂ©cise la façon dont Nodal est exprimĂ© et rĂ©gulĂ© aux stades prĂ© et pĂ©ri-implantatoires mais pose in fine la question du rĂŽle de cette molĂ©cule et de sa voie de signalisation Ă  ces stades.PARIS-BIUSJ-Physique recherche (751052113) / SudocSudocFranceF

    Activin/Nodal signalling before implantation: setting the stage for embryo patterning.

    No full text
    International audienceActivins and Nodal are members of the transforming growth factor beta (TGF-ÎČ) family of growth factors. Their Smad2/3-dependent signalling pathway is well known for its implication in the patterning of the embryo after implantation. Although this pathway is active early on at preimplantation stages, embryonic phenotypes for loss-of-function mutations of prominent components of the pathway are not detected before implantation. It is only fairly recently that an understanding of the role of the Activin/Nodal signalling pathway at these stages has started to emerge, notably from studies detailing how it controls the expression of target genes in embryonic stem cells. We review here what is currently known of the TGF-ÎČ-related ligands that determine the activity of Activin/Nodal signalling at preimplantation stages, and recent advances in the elucidation of the Smad2/3-dependent mechanisms underlying developmental progression

    [Epigenetic regulation of pluripotency in the early mouse embryo]

    No full text
    International audienc

    A novel Nodal enhancer dependent on pluripotency factors and Smad2/3 signaling conditions a regulatory switch during epiblast maturation

    Get PDF
    During early development, modulations in the expression of Nodal, a TGFÎČ family member, determine the specification of embryonic and extra-embryonic cell identities. Nodal has been extensively studied in the mouse, but aspects of its early expression remain unaccounted for. We identified a conserved hotspot for the binding of pluripotency factors at the Nodal locus and called this sequence “highly bound element” (HBE). Luciferase-based assays, the analysis of fluorescent HBE reporter transgenes, and a conditional mutation of HBE allowed us to establish that HBE behaves as an enhancer, is activated ahead of other Nodal enhancers in the epiblast, and is essential to Nodal expression in embryonic stem cells (ESCs) and in the mouse embryo. We also showed that HBE enhancer activity is critically dependent on its interaction with the pluripotency factor Oct4 and on Activin/Nodal signaling. Use of an in vitro model of epiblast maturation, relying on the differentiation of ESCs into epiblast stem cells (EpiSCs), revealed that this process entails a shift in the regulation of Nodal expression from an HBE-driven phase to an ASE-driven phase, ASE being another autoregulatory Nodal enhancer. Deletion of HBE in ESCs or in EpiSCs allowed us to show that HBE, although not necessary for Nodal expression in EpiSCs, is required in differentiating ESCs to activate the differentiation-promoting ASE and therefore controls this regulatory shift. Our findings clarify how early Nodal expression is regulated and suggest how this regulation can promote the specification of extra-embryonic precusors without inducing premature differentiation of epiblast cells. More generally, they open new perspectives on how pluripotency factors achieve their function
    corecore